Veristat to Attend Bio Europe Spring 2017 Event

February 27, 2017

Join Veristat and nearly 2,500 professionals from biotech, pharma, finance and life sciences industry across Europe’s most innovative biopharma clusters at the  Bio Europe Spring 2017 event.

Read More

Let's Honor Rare Disease Day 2017 |  February 28, 2017

February 23, 2017


What is Rare Disease Day?

This year's Rare Disease Day is being celebrated on Tuesday, February 28,  2017 and it  marks the tenth year that Rare Disease Day has been celebrated.   On  this day,  thousands of organizations from around the world will hold awareness-raising activities centered on the theme of raising awareness for rare disease research.

Read More

Veristat to Exhibit at Outsourcing in Clinical Trials West Coast 2017

February 2, 2017

Veristat is excited to join over 700 clinical research professionals from the bay area  to discuss strategies for clinical outsourcing and address the clinical operations challenges that arise throughout the clinical development and submission process at the Outsourcing in Clinical Trials West Coast 2017 conference.

Read More

Join Us for An Opening Reception at Our New North Carolina Office

January 18, 2017

Veristat is excited to announce that it has officially opened its new office in Morrisville, North Carolina.    

We are hosting an opening reception on Thursday, March 2, 2017  to celebrate the opening of this new office.

Read More

Veristat to Exhibit at the 2016 MassBio CRO/CMO Symposium

November 29, 2016

Join Veristat and more than 300 local attendees to discuss and evaluate the best practices that have evolved in shortening time to market at the 5th Annual MassBio CRO/CMO Symposium.

Read More

Veristat to Attend the American Society of Hematology Annual Meeting (ASH)

November 17, 2016

Join Veristat at the ASH Annual Meeting & Exposition, the world’s largest hematology conference geared towards clinicians, researchers and scientists who are looking to further the understanding, diagnosis, treatment, and prevention of blood disorders. Today, the ASH annual meeting attracts more than 20,000 attendees from all over the world.

Read More

Veristat to present at Harvard Drug Development Boot Camp

November 14, 2016

Come join Veristat and a panel of drug development experts for a two day intensive boot camp targeted for executive level leaders who make drug development decisions on a daily basis.

Read More

John Balser to Moderate Forum on Adaptive Designs in Clinical Trials

November 2, 2016

Come join the conversation being moderated by John Balser, PhD, President of Veristat.  Bring your challenging questions and be prepared to share your experiences with adaptive designs.

Have you ever wondered how biotech and pharma companies make informed decisions as to whether an adaptive design would be useful in their development programs?

Read More

Veristat to Present Short-Course on Adaptive Clinical Trial Design at BASS XXIII

September 30, 2016


Join Veristat during the last three days of the BASS XXIII program for a short course titled:

Read More

Veristat to Attend the European Society for Medical Oncology (ESMO) Conference

September 29, 2016

Join Veristat and other Oncology researchers, clinicians and patients at the ESMO 2016 Conference, focused on finding the most effective cancer treatment solutions available today.   ESMO 2016 offers a top-notch scientific and educational program created by international experts in oncology.  Some key topic areas include:

Read More